Intellia Therapeutics, Inc. (NTLA)
12.71
-0.02
(-0.16%)
USD |
NASDAQ |
Sep 01, 14:54
Intellia Therapeutics Total Long Term Debt (Quarterly) : 50.07M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 50.07M |
| March 31, 2026 | 61.40M |
| December 31, 2025 | 66.85M |
| September 30, 2025 | 70.59M |
| June 30, 2025 | 75.60M |
| March 31, 2025 | 80.49M |
| December 31, 2024 | 189.95M |
| September 30, 2024 | 82.45M |
| June 30, 2024 | 87.33M |
| March 31, 2024 | 92.10M |
| December 31, 2023 | 96.75M |
| September 30, 2023 | 101.26M |
| June 30, 2023 | 105.58M |
| March 31, 2023 | 109.80M |
| December 31, 2022 | 114.02M |
| September 30, 2022 | 84.10M |
| June 30, 2022 | 60.00M |
| March 31, 2022 | 62.48M |
| December 31, 2021 | 64.91M |
| September 30, 2021 | 67.27M |
| June 30, 2021 | 63.26M |
| Date | Value |
|---|---|
| March 31, 2021 | 64.49M |
| December 31, 2020 | 33.61M |
| September 30, 2020 | 16.00M |
| June 30, 2020 | 17.35M |
| March 31, 2020 | 18.67M |
| December 31, 2019 | 12.63M |
| September 30, 2019 | 14.14M |
| June 30, 2019 | 14.60M |
| March 31, 2019 | 15.13M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 232.15M |
| Twist Bioscience Corp. | 84.96M |
| Tenaya Therapeutics, Inc. | 1.07M |
| Moderna, Inc. | 1.266B |
| Revolution Medicines, Inc. | 1.174B |